| HOME >> BIOLOGY >> TECHNOLOGY |
SANTA PAULA, Calif., Sept. 10 /PRNewswire/ -- Abrisa, Inc., a global leader in industrial glass fabrication products and precision thin film optical coatings, recently named industry veteran Jim Veler as President and Chief Executive Officer. The appointment became effective June 1, 2009.
Prior to joining Abrisa, Mr. Veler was Vice President and General Manager of Agilent Technologies' Wireless Manufacturing Organization (Santa Rosa, CA). His duties included the management of 1600 employees and full responsibility for the manufacturing operations of two semiconductor fabs as well as Agilents' Aerospace Defense Systems' business.
Jim Veler notes, "My vision is to transform Abrisa from its roots as a respected global leader of high-volume industrial glass fabrication to an innovator in providing precision optical product solutions. While we will be focusing on several markets, we are targeting substantial growth in four key segments: defense, medical, display, and lighting. Abrisa has gained tremendous momentum with our two recent acquisitions and we plan to acquire at least one more company to help us better serve these strategic markets."
"What makes Veler an excellent choice for the Abrisa helm is his vast experience in the thin film industry," says Mr. Tom Portland, Chairman of the Abrisa Board. He adds, "Jim rose to the level of Vice President and General Manager of the Custom Optics Products Group, the legacy Optical Coating Laboratory Inc. (OCLI) business, now part of JDS Uniphase (Santa Rosa, CA). In his role at OCLI, he managed all aspects of the business including sales, marketing, R&D, business development, and operations. Jim brings his experience at OCLI to his new role here at Abrisa. Jim has already taken his first steps towards achieving his vision by hiring two industry-renowned sales managers. Jim Hooker (previously with Deposition Sciences and Optical Coating Laboratori
'/>"/>
| SOURCE Abrisa, Inc. Copyright©2009 PR Newswire. All rights reserved |
Related biology technology :
1. PharmaVentures Corporate Advisory Appoints Nikki Watkins as Practice Head, Product & Portfolio Strategy
2. Hovione Appoints Terry Lambe to its Board of Directors
3. Sechrist Increases Focus on International Markets; Appoints William Preuit Senior Vice President
4. China Biologic Products Appoints Director of Research and Development
5. PriceSpective Appoints Colasante as a Vice President and Murdoch as a Director
6. iPierian Appoints Dr. Matthew J. Plunkett as Chief Financial Officer
7. Affitech Appoints Dr Robert Burns as CEO and Dr Alexander Duncan as SVP Research & Development
8. ERT Appoints New Associate Director of Business Development - Japan
9. NeurogesX Appoints New Board Director and Audit Committee Chairman
10. Orexigen(R) Therapeutics Appoints Mark Booth Chief Commercial Officer
11. Eiger BioPharmaceuticals Appoints Paul Truex to Board of Directors
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |